We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.39B
AUM Growth
+$62.3M
Cap. Flow
-$30.3M
Cap. Flow %
-2.17%
Top 10 Hldgs %
32.32%
Holding
406
New
134
Increased
46
Reduced
56
Closed
155

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$229M
2
PYPL icon
PayPal
PYPL
+$15.3M
3
FDX icon
FedEx
FDX
+$12.7M
4
JWN
Nordstrom
JWN
+$12.1M
5
MU icon
Micron Technology
MU
+$12M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.79%
2 Industrials 8.58%
3 Healthcare 7.87%
4 Technology 6.57%
5 Consumer Staples 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMN icon
151
CALL
Eastman Chemical
EMN
$7.79B
$1.76M 0.13%
+22,200
New +$1.71M
YEXT icon
152
PUT
Yext
YEXT
$564M
$1.73M 0.12%
+120,000
New +$1.86M
SKX
153
PUT
DELISTED
Skechers
SKX
$1.73M 0.12%
+40,000
New +$1.58M
CHMA
154
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.72M 0.12%
347,182
-156,480
-31% -$815K
ADV icon
155
Advantage Solutions
ADV
$542M
$1.7M 0.12%
6,525
+4,525
+226% +$1.16M
DCO icon
156
PUT
Ducommun
DCO
$2.68B
$1.68M 0.12%
+33,300
New +$1.53M
YUM icon
157
Yum! Brands
YUM
$41.4B
$1.67M 0.12%
+16,555
New +$1.71M
RACE icon
158
PUT
Ferrari
RACE
$68.6B
$1.66M 0.12%
+10,000
New +$1.62M
EGIO
159
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.66M 0.12%
+10,139
New +$1.61M
XLP icon
160
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$1.61M 0.12%
25,586
-21,163
-45% -$1.3M
MTUM icon
161
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
$1.59M 0.11%
12,657
+5,880
+87% +$714K
MNTA
162
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.58M 0.11%
80,000
+60,000
+300% +$959K
BA icon
163
CALL
Boeing
BA
$175B
$1.53M 0.11%
+4,700
New +$1.66M
TLT icon
164
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$43.1B
$1.49M 0.11%
+11,000
New +$1.53M
IHI icon
165
iShares US Medical Devices ETF
IHI
$3.14B
$1.48M 0.11%
+33,528
New +$1.41M
TVRD
166
Tvardi Therapeutics
TVRD
$22.9M
$1.45M 0.1%
+2,500
New +$1.75M
ADNT icon
167
CALL
Adient
ADNT
$1.7B
$1.41M 0.1%
+66,500
New +$1.48M
DIS icon
168
Walt Disney
DIS
$172B
$1.38M 0.1%
9,511
-46,805
-83% -$6.53M
XLF icon
169
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$1.32M 0.09%
42,745
+7,119
+20% +$209K
MIME
170
DELISTED
Mimecast Limited
MIME
$1.26M 0.09%
+29,013
New +$1.21M
FSLY icon
171
Fastly Inc
FSLY
$3.26B
$1.13M 0.08%
+56,339
New +$1.19M
EW icon
172
Edwards Lifesciences
EW
$48.2B
$1.11M 0.08%
14,340
-92,826
-87% -$7.25M
VNTR
173
CALL
DELISTED
Venator Materials PLC
VNTR
$1.11M 0.08%
288,900
+280,600
+3,381% +$913K
AMLP icon
174
Alerian MLP ETF
AMLP
$12.9B
$1.1M 0.08%
+25,844
New +$1.08M
DBI icon
175
CALL
Designer Brands
DBI
$322M
$1.09M 0.08%
+69,500
New +$1.15M

Similar funds

J. Goldman & Co's Q4 2019 Portfolio in Review

As of Q4 2019, J. Goldman & Co held 406 positions worth $1.39B, up 4.7% from $1.33B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

J. Goldman & Co's Q4 2019 filing shows 134 new, 46 increased, 56 reduced and 155 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 741,000 shares worth $240M. The largest sale was Virgin Galactic, an estimated $37.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • J. Goldman & Co's largest Q4 2019 buy was iShares Core S&P 500 ETF: 741,000 shares worth $240M.
  • J. Goldman & Co added most to FedEx in Q4 2019, an estimated $12.7M increase.
  • J. Goldman & Co's biggest Q4 2019 reduction was Jack in the Box, cutting an estimated $10.6M.
  • J. Goldman & Co fully exited Virgin Galactic in Q4 2019, selling an estimated $37.5M.
  • J. Goldman & Co's ten largest holdings make up 32% of its $1.39B portfolio in Q4 2019.
  • J. Goldman & Co opened 134 new positions and closed 155 in Q4 2019.
  • J. Goldman & Co's portfolio value rose 4.7% quarter-over-quarter to $1.39B.

Based on J. Goldman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.